State Street Corp Aspira Women'S Health Inc. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$0.38 - $1.07 $18,506 - $52,109	-48,700 Reduced 16.16%	252,685 $94,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $594,158 - $1.62 Million	-1,485,397 Reduced 83.13%	301,385 $177,000
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $183,243 - $376,898	208,231 Added 13.19%	1,786,782 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $301,364 - $634,158	184,886 Added 13.27%	1,578,551 $2.79 Million
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $2.69 Million - $4.62 Million	-843,469 Reduced 37.7%	1,393,665 $4.53 Million
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $383,590 - $548,903	80,249 Added 3.72%	2,237,134 $12.6 Million
Q1 2021 May 17, 2021	BUY	$5.9 - $9.13 $5.37 Million - $8.31 Million	910,235 Added 73.01%	2,156,885 $14.6 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $649,194 - $1.45 Million	216,398 Added 21.0%	1,246,650 $8.37 Million
Q3 2020 Nov 10, 2020	BUY	$2.54 - $4.56 $637,359 - $1.14 Million	250,929 Added 32.2%	1,030,252 $3.18 Million
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $607,871 - $4.09 Million	779,323 New	779,323 $2.99 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.